Meleagrin

• Background:

  A novel alkaloid biosynthesized via the roquefortine branched biosynthetic pathway.1,2 Displays excellent ATP-competitive c-MET inhibition, inhibiting the growth, migration and invasion of numerous breast cancer cell lines.3 Also has been shown to inhibit the bacterial enoyl-acyl carrier protein reductase (Fabl) with IC50s in the 33-40 μM range.4

• Conjugation:

  Unconjugated

• Buffer:

  Tan lyophilized solid

• Storage Conditions:

  -20°C